USPTO serial 88465392
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | Jul 25, 2019 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 9, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 7, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 31, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 26, 2022 | IUAF | USE AMENDMENT FILED | — |
| May 26, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 4, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 2, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 2, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 2, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 7, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 6, 2021 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 6, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 6, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 6, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 5, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 3, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 14, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 13, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 5, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 4, 2021 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jan 4, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 4, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 4, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 4, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 3, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 21, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 20, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 7, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 6, 2020 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 6, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 6, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 6, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 6, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 3, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 3, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 31, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2019 | NWAP | NEW APPLICATION ENTERED | — |